GC Cell Corporation (KOSDAQ:144510)
South Korea · Delayed Price · Currency is KRW 13,950
-280 (-1.97%)
Sep 22, 2026, 3:30 PM KST
GC Cell Market Cap
GC Cell has a market cap or net worth of 209.63 billion as of September 22, 2026. Its market cap has decreased by -32.12% in one year.
Market Cap
209.63B
Enterprise Value
320.27B
Revenue
162.00B
Ranking
n/a
PE Ratio
n/a
Stock Price
13,950.00
ChartMarket Cap Chart
Since June 23, 2016, GC Cell's market cap has decreased from 507.65B to 209.63B, a decrease of -58.71%. That is a compound annual growth rate of -8.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 209.63B | -43.86% |
| Dec 30, 2025 | 373.42B | 4.85% |
| Dec 30, 2024 | 356.14B | -47.90% |
| Dec 28, 2023 | 683.53B | -3.46% |
| Dec 29, 2022 | 708.04B | -55.94% |
| Dec 30, 2021 | 1.61T | 65.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Proteina | 386.78B |
| MEDIPOST | 346.69B |
| SillaJen | 305.51B |
| Genomictree | 293.56B |
| Bioneer | 227.65B |
| NeoImmuneTech | 195.56B |
| HLB Therapeutics | 169.05B |
| GC Genome | 163.19B |